Switching the nucleoside reverse transcriptase inhibitor backbone to tenofovir disoproxil fumarate + emtricitabine promptly improves triglycerides and low-density lipoprotein cholesterol in dyslipidaemic patients-Reference-Cited by-同舟云学术

Switching the nucleoside reverse transcriptase inhibitor backbone to tenofovir disoproxil fumarate + emtricitabine promptly improves triglycerides and low-density lipoprotein cholesterol in dyslipidaemic patients

Published:2010-01-06 Issue:3 Volume:65 Page:556-561
ISSN:0305-7453
Container-title:Journal of Antimicrobial Chemotherapy
language:en
Short-container-title:Journal of Antimicrobial Chemotherapy

Author:

Valantin M. A.,Bittar R.,de Truchis P.,Bollens D.,Slama L.,Giral P.,Bonnefont-Rousselot D.,Petour P.,Aubron-Olivier C.,Costagliola D.,Katlama C.,

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology,Microbiology (medical)

Link

http://academic.oup.com/jac/article-pdf/65/3/556/2232578/dkp462.pdf

Reference21 articles.

1. Risk Factors for Coronary Heart Disease in Patients Treated for Human Immunodeficiency Virus Infection Compared with the General Population

2. CD4+ Count–Guided Interruption of Antiretroviral Treatment

3. Increased risk of myocardial infarction with duration of protease inhibitor therapy in HIV-infected men

4. Cardiovascular and Cerebrovascular Events in Patients Treated for Human Immunodeficiency Virus Infection

5. Class of Antiretroviral Drugs and the Risk of Myocardial Infarction

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lipid metabolism and renal function changes switching from Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide therapy in CHB patients;2024-04-02

2. Broadening access to tenofovir alafenamide for the treatment and prevention of HIV-1 infection;Expert Review of Clinical Pharmacology;2023-09-07

3. Young age is a key determinant of body weight gain after switching from tenofovir disoproxil fumarate to tenofovir alafenamide in Japanese people living with HIV;Journal of Infection and Chemotherapy;2023-02

4. Cardiovascular diseases in HIV patients;Cardiovascular Prevention and Pharmacotherapy;2022-07-31

5. Real‐life impact of tenofovir disoproxil fumarate and entecavir therapy on lipid profile, glucose, and uric acid in chronic hepatitis B patients;Journal of Medical Virology;2022-07-13